Three priorities: patient safety, innovation and productivity
First written in FY2023. 5 of 7 entries say "Restated". Latest entry: FY2026.
No other company in this theme has enough history to compare yet.
- FY2026ReframedAnnual report
「The Group seeks to execute the strategies described above through initiatives centered on three strategic foundations: growth through innovation, simplification, and responsible action.」
The company revised the wording and execution framework from the previous three priorities of patient safety and sustainability, innovation for growth, and improved productivity to the three strategic foundations of the new management strategy. - FY2025RestatedAnnual report
「Since April 2023, the company has positioned three areas as its basic guiding principles: patient safety and sustainability, innovation for growth, and improved productivity.」
The company reaffirmed its three basic guiding principles, namely patient safety and sustainability, innovation for growth, and improved productivity, in its full-year report. - FY2025-H1RestatedAnnual report
「Under the 3 priorities of “patient safety and sustainability,” “innovation for growth,” and “productivity improvement,” we continue to pursue our transformation into a global medtech company.」
The company continues to pursue three priorities: patient safety and sustainability, innovation for growth, and improved productivity. - FY2024-Q3RestatedAnnual report
「Despite this environment, the Olympus Group continues to pursue its transformation into a global medtech company under the 3 priorities of patient safety and sustainability, innovation for growth, and productivity improvement, in line with the management strategy announced in May 2023.」
The 3 priorities of patient safety and sustainability, innovation for growth, and productivity improvement were reaffirmed in FY2024-Q3. - FY2024-Q2RestatedAnnual report
「Despite this environment, the Olympus Group continues to pursue its transformation into a global medtech company under the 3 priorities of patient safety and sustainability, innovation for growth, and productivity improvement, in line with the management strategy announced in May 2023.」
The management strategy announced in May 2023 and the 3 priorities of patient safety and sustainability, innovation for growth, and productivity improvement were reaffirmed. - FY2024-Q1RestatedAnnual report
「In line with the management strategy announced in May 2023, our Group continues to pursue its transformation into a global medtech company under the 3 priorities of “patient safety and sustainability,” “innovation for growth,” and “productivity improvement.”」
The 3 priorities of patient safety and sustainability, innovation for growth, and productivity improvement were reaffirmed as the pillars for executing the new management strategy. - FY2023First statedAnnual report
「Since April 2023, we have identified “patient safety and sustainability,” “innovation for growth,” and “productivity improvement” as the 3 priorities.」
Since April 2023, 3 items were newly identified as management priorities: patient safety and sustainability, innovation for growth, and productivity improvement.